Table 2.
Discovery Cohort | Replication Cohort | Pooled Cohort | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytokine (pg/mL) | PREOP | PACU | POD2 | POD1M | PREOP | PACU | POD2 | POD1M | PREOP | PACU | POD2 | POD1M |
IL-1β | 0.32* | 0.53* | 0.31 | 0.27 | −0.09 | 0.13 | 0.29 | 0.12 | 0.26 | 0.28 | 0.31 | 0.27 |
IL-2 | 1.26* | 1.46** | 1.26** | 1.16 | 0.45 | 0.17 | 0.51 | 0.52 | 0.99* | 0.77* | 1.07** | 0.73* |
IL-4 | −6.43 | −4.33 | −9.18 | −15.72 | 12.88 | 9.82 | 12.03 | 7.27 | 7.13 | 0.54 | −1.56 | −2.32 |
IL-5 | 0.22 | 0.68 | 0.16 | 0.63 | 0.16 | −0.15 | −1.39* | 0.44 | 0.19 | 0.19 | −0.52 | 0.57 |
IL-6 | 1.11 | 9.13 | 50.44** | 0.16 | 0.94 | 6.29 | 20.17* | 0.90 | 1.01 | 7.17* | 39.35** | 0.49 |
IL-8 | 1.60* | 2.01 | 0.89 | 0.20 | −1.30 | −1.79 | 0.81 | −0.34 | 0.86 | 0.68 | 0.89 | −0.18 |
IL-10 | 0.04 | 0.10 | 0.74 | −0.01 | −0.05 | 0.21 | 0.10 | −0.25 | 0.00 | 0.10 | 0.27 | −0.11 |
IL-12 | −0.25 | 0.00 | −2.62 | −6.40* | −3.89 | −4.71 | −4.25 | −1.47 | −2.64 | −1.73 | −2.88 | −4.24* |
IFN-γ | 0.00 | 0.00 | 0.00 | 0.04 | 0.00 | 0.01 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.03 |
GMCSF | 0.32 | 0.28 | 0.60 | −0.07 | −1.11 | −1.36 | −1.33 | −0.44 | −0.58 | −0.49 | −0.45 | −0.22 |
TNF-α | 2.39 | 2.52 | 3.64 | 3.15 | 1.83 | 2.36 | 2.84 | 2.39 | 2.12 | 2.52 | 3.22 | 3.10* |
VEGF | 5.61 | −0.13 | 5.95* | 3.47 | 0.21 | −1.28 | 1.84 | −0.62 | 3.50 | −0.34 | 4.10* | 0.83 |
Notes: GMCSF = granulocyte macrophage colony-stimulating factor; IFN-γ = interferon-gamma; IL = interleukin; PACU = postanesthesia care unit; POD1M = 30 days postoperation; POD2 = postoperative day 2; PREOP = preoperative; TNF-α = tumor necrosis factor-alpha; VEGF = vascular endothelial growth factor. Bold values indicate cytokines significant in the pooled cohort.
*p < .05; **p < .01.